These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26769719)

  • 1. Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization.
    Lindgren I; Bååth M; Uvebrant K; Dejmek A; Kjaer L; Henic E; Bungum M; Bungum L; Cilio C; Leijonhufvud I; Skouby S; Andersen CY; Giwercman YL
    Hum Reprod; 2016 Mar; 31(3):672-83. PubMed ID: 26769719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin receptor polymorphisms (FSHR N680S and LHCGR N312S) are not predictive of clinical outcome and live birth in assisted reproductive technology.
    Pirtea P; de Ziegler D; Marin D; Sun L; Tao X; Ayoubi JM; Franasiak J; Scott RT
    Fertil Steril; 2022 Sep; 118(3):494-503. PubMed ID: 35842313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study.
    Simoni M; Santi D; Negri L; Hoffmann I; Muratori M; Baldi E; Cambi M; Marcou M; Greither T; Baraldi E; Tagliavini S; Carra D; Lombardo F; Gandini L; Pallotti F; Krausz C; Rastrelli G; Ferlin A; Menegazzo M; Pignatti E; Linari F; Marino M; Benaglia R; Levi-Setti PE; Behre HM
    Hum Reprod; 2016 Sep; 31(9):1960-9. PubMed ID: 27329968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin receptor variants are linked to cumulative live birth rate after in vitro fertilization.
    Lindgren I; Nenonen H; Henic E; Bungum L; Prahl A; Bungum M; Leijonhufvud I; Huhtaniemi I; Yding Andersen C; Lundberg Giwercman Y
    J Assist Reprod Genet; 2019 Jan; 36(1):29-38. PubMed ID: 30232643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variations altering FSH action affect circulating hormone levels as well as follicle growth in healthy peripubertal girls.
    Busch AS; Hagen CP; Almstrup K; Main KM; Juul A
    Hum Reprod; 2016 Apr; 31(4):897-904. PubMed ID: 26905078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of FSHR and LHCGR gene variants with ovarian reserve and clinical pregnancy rates.
    Guo C; Yu H; Feng G; Lv Q; Liu X; Liu X
    Reprod Biomed Online; 2021 Sep; 43(3):561-569. PubMed ID: 34391684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia.
    Polyzos NP; Neves AR; Drakopoulos P; Spits C; Alvaro Mercadal B; Garcia S; Ma PQM; Le LH; Ho MT; Mertens J; Stoop D; Tournaye H; Vuong NL
    Hum Reprod; 2021 May; 36(6):1711-1721. PubMed ID: 33889959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of polymorphisms in FSHR gene on late follicular phase progesterone and estradiol serum levels in predicted normoresponders.
    Neves AR; Vuong NL; Blockeel C; Garcia S; Alviggi C; Spits C; Ma PQM; Ho MT; Tournaye H; Polyzos NP
    Hum Reprod; 2022 Oct; 37(11):2646-2654. PubMed ID: 36069495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age.
    La Marca A; Papaleo E; Alviggi C; Ruvolo G; De Placido G; Candiani M; Cittadini E; De Michele F; Moriondo V; Catellani V; Volpe A; Simoni M
    Hum Reprod; 2013 May; 28(5):1369-74. PubMed ID: 23504007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
    König TE; van der Houwen LE; Overbeek A; Hendriks ML; Beutler-Beemsterboer SN; Kuchenbecker WK; Renckens CN; Bernardus RE; Schats R; Homburg R; Hompes PG; Lambalk CB
    Hum Reprod; 2013 Oct; 28(10):2804-12. PubMed ID: 23838159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
    Koedooder R; Singer M; Schoenmakers S; Savelkoul PHM; Morré SA; de Jonge JD; Poort L; Cuypers WJSS; Beckers NGM; Broekmans FJM; Cohlen BJ; den Hartog JE; Fleischer K; Lambalk CB; Smeenk JMJS; Budding AE; Laven JSE
    Hum Reprod; 2019 Jun; 34(6):1042-1054. PubMed ID: 31119299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteal granulosa cells from natural cycles are more capable of maintaining their viability, steroidogenic activity and LH receptor expression than those of stimulated IVF cycles.
    Bildik G; Akin N; Seyhan A; Esmaeilian Y; Yakin K; Keles I; Balaban B; Ata B; Urman B; Oktem O
    Hum Reprod; 2019 Feb; 34(2):345-355. PubMed ID: 30520979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Lh polymorphisms and r-hLh supplementation in GnRh agonist treated ART cycles: A cross sectional study.
    G A R; Cheemakurthi R; Prathigudupu K; Balabomma KL; Kalagara M; Thota S; Kota M
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():119-125. PubMed ID: 29408742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome.
    Almawi WY; Hubail B; Arekat DZ; Al-Farsi SM; Al-Kindi SK; Arekat MR; Mahmood N; Madan S
    J Assist Reprod Genet; 2015 Apr; 32(4):607-14. PubMed ID: 25649397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.